Turn Around Your Teen s Nutrition newsmax.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsmax.com Daily Mail and Mail on Sunday newspapers.
Trial does not support early coronary CTA among higher-risk patients with suspected ACS Source:
Gray A, et al. LBS.07: Randomized trials – Brain, kidney and heart. Presented at: American Heart Association Scientific Sessions; Nov. 13-17, 2020 (virtual meeting). Disclosures: The RAPID CTCA trial was funded by the National Institute for Health Research health technology assessment program. Gray reports no relevant financial disclosures. Hochman was an investigator on the ISCHEMIA trial which received support from Abbott, Arbor, AstraZeneca, Medtronic, Merck Sharp and Dohme, Omron, St. Jude Medical and Volcano. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on
Dec 23, 2020
Participants without cardiovascular disease but who were at increased risk were randomly assigned to receive a polypill (i.e. 1 statin with 3 blood pressure-lowering drugs) or placebo and to receive aspirin or placebo. With 4.6 years follow-up, the incidence of cardiovascular events was lower among participants receiving both the polypill and aspirin than among those receiving both placebos.
Physician’s Weekly interviews the lead study investigator, Prof. Salim Yusuf (Population Health Research Institute, Hamilton, Canada) who presented the results of the TIPS-3 trial at the American Heart Association Scientific Sessions 2020 [1].
TIPS-3 randomised 5,713 people, mostly of South Asian ancestry, who did not have cardiovascular disease but were classified as being at intermediate or high risk as measured by the INTERHEART Risk Score. The polypill contains 40 milligrams of simvastatin, 100 milligrams of atenolol, 25 milligrams of hydrochlorothiazide, and 10 milligram
Five ways to reset your goals for 2021
As a new ONS study reveals all the bad habits we ve picked up during lockdown, here s how to get your year off to a healthy start
17 December 2020 • 8:09am
Did you pick up some bad habits over lockdown? If the answer is yes, then you aren’t the only one. While it may have started out all banana bread baking, Joe Wicks workouts and daily walks around the park, a new study by the Office for National Statistics suggests our healthy habits wore off. According to the research, we were drinking more, moving less and addicted to TV throughout the restrictions.
December 11, 2020
A new analysis of the ISCHEMIA trial reveals its results are highly contingent on how myocardial infarction is defined, with investigators reporting a significant treatment difference between the invasive and conservative strategies when counting MIs using the more-sensitive biomarker: cardiac troponin (cTn).
When investigators analyzed events based on the secondary MI definition, which assessed PCI- and CABG-related infarctions using cTn levels as opposed to CK-MB, the conservative strategy of guideline-directed medical therapy was associated with a significantly lower risk of the study’s primary endpoint, a composite of cardiovascular death, MI, hospitalization for unstable angina, heart failure, or resuscitated cardiac arrest, and a lower risk of cardiovascular death or MI, which was a secondary endpoint.